Cargando…

Creation of a long-acting nanoformulated dolutegravir

Potent antiretroviral activities and a barrier to viral resistance characterize the human immunodeficiency virus type one (HIV-1) integrase strand transfer inhibitor dolutegravir (DTG). Herein, a long-acting parenteral DTG was created through chemical modification to improve treatment outcomes. A hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sillman, Brady, Bade, Aditya N., Dash, Prasanta K., Bhargavan, Biju, Kocher, Ted, Mathews, Saumi, Su, Hang, Kanmogne, Georgette D., Poluektova, Larisa Y., Gorantla, Santhi, McMillan, JoEllyn, Gautam, Nagsen, Alnouti, Yazen, Edagwa, Benson, Gendelman, Howard E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799307/ https://www.ncbi.nlm.nih.gov/pubmed/29402886 http://dx.doi.org/10.1038/s41467-018-02885-x

Ejemplares similares

Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques
por: McMillan, JoEllyn, et al.
Publicado: (2017)

ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018)

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
por: Kanmogne, Georgette D, et al.
Publicado: (2012)

Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
por: Zhou, Tian, et al.
Publicado: (2017)

Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine
por: Guo, Dongwei, et al.
Publicado: (2017)

Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim, Ibrahim M, et al.
Publicado: (2019)

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment
por: Bade, Aditya N., et al.
Publicado: (2021)

A Year-Long Extended Release Nanoformulated Cabotegravir Prodrug
por: Kulkarni, Tanmay A., et al.
Publicado: (2020)

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
por: Deodhar, Suyash, et al.
Publicado: (2022)

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
por: Cobb, Denise A., et al.
Publicado: (2021)

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Gautam, Nagsen, et al.
Publicado: (2021)

Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress
por: Montenegro-Burke, J. Rafael, et al.
Publicado: (2018)

Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals
por: Zhou, Tian, et al.
Publicado: (2018)

Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice
por: Su, Hang, et al.
Publicado: (2021)

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice
por: Bhargavan, Biju, et al.
Publicado: (2021)

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations
por: Balkundi, Shantanu, et al.
Publicado: (2011)

Immune Activations and Viral Tissue Compartmentalization During Progressive HIV-1 Infection of Humanized Mice
por: Su, Hang, et al.
Publicado: (2019)

Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy
por: Martinez-Skinner, Andrea L., et al.
Publicado: (2015)

Epigenetics, N-myrystoyltransferase-1 and casein kinase-2-alpha modulates the increased replication of HIV-1 CRF02_AG, compared to subtype-B viruses
por: Bhargavan, Biju, et al.
Publicado: (2019)

SARS-CoV-2 Spike Proteins and Cell–Cell Communication Inhibits TFPI and Induces Thrombogenic Factors in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for COVID-19 Coagulopathy Pathogenesis
por: Bhargavan, Biju, et al.
Publicado: (2022)

SARS-CoV-2 Spike Proteins and Cell–Cell Communication Induce P-Selectin and Markers of Endothelial Injury, NETosis, and Inflammation in Human Lung Microvascular Endothelial Cells and Neutrophils: Implications for the Pathogenesis of COVID-19 Coagulopathy
por: Bhargavan, Biju, et al.
Publicado: (2023)

Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution
por: Kevadiya, Bhavesh D., et al.
Publicado: (2018)

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
por: Balkundi, Shantanu, et al.
Publicado: (2010)

Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice
por: Dash, Prasanta K., et al.
Publicado: (2019)

Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection
por: Epstein, Adrian A., et al.
Publicado: (2013)

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
por: Araínga, Mariluz, et al.
Publicado: (2015)

Animal models for studies of HIV‐1 brain reservoirs
por: Waight, Emiko, et al.
Publicado: (2022)

Data in support of NFκB and JNK pathways involvement in TLR3-mediated HIV-1 transactivation, expression of IL-6 and transcription factors associated with HIV-1 replication
por: Bhargavan, Biju, et al.
Publicado: (2015)

A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy
por: Araínga, Mariluz, et al.
Publicado: (2017)

Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice
por: Mathews, Saumi, et al.
Publicado: (2019)

CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice
por: Dash, Prasanta K., et al.
Publicado: (2023)

A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection
por: Dash, Prasanta K., et al.
Publicado: (2021)

Humanized Mice for Studies of HIV-1 Persistence and Elimination
por: Zhang, Chen, et al.
Publicado: (2023)

Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes
por: Edagwa, Benson J., et al.
Publicado: (2014)

Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis
por: Shahnaz, Gul, et al.
Publicado: (2017)

Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains
por: Li, Weizhe, et al.
Publicado: (2017)

Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice
por: Su, Hang, et al.
Publicado: (2020)

Antiretroviral Drug Metabolism in Humanized PXR-CAR-CYP3A-NOG Mice
por: McMillan, JoEllyn M., et al.
Publicado: (2018)

HIV-1 cellular and tissue replication patterns in infected humanized mice
por: Araínga, Mariluz, et al.
Publicado: (2016)

Humanized Mice for Infectious and Neurodegenerative disorders
por: Dash, Prasanta K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0kou3ujpvan9ffth0ks1nkpth3